InvestorsHub Logo
Followers 1
Posts 28
Boards Moderated 0
Alias Born 05/08/2015

Re: skitahoe post# 4544

Thursday, 06/18/2015 4:58:24 PM

Thursday, June 18, 2015 4:58:24 PM

Post# of 18784
No Gary,

EMA just said the same FDA did. Continue folks and will see.
The 18-month period it is what the company estimated. An exercise of honesty as I see it.

Anyway, Macrilen is not the thing. Not because its time frame, not because its low-medium reward.

But we have a thing, and thats ZoptEC. Not just because it, but it probably could give a push to other drugs of their pipeline. As other AEZSs pursue similar correlated paths.

ZopEC december completion is the start or the end, there is not anymore.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News